"Consultant clinical oncologist at Addenbrooke’s and chief investigator for the UK arm of the study, Dr Thankamma Ajithkumar, says the study is focusing on the three most aggressive and deadly cancers: advanced small-cell lung cancer, advanced pancreatic cancer and glioblastoma, a type of brain tumour.
Rather than focusing on why cancer patients do not survive, this study seeks to understand what it is that makes them live. By investigating the biology of this elite group of super-survivors, the study aims to discover insights that could potentially benefit and improve outcomes for all patients.Dr Thankamma Ajithkumar
Researchers intend to gather tumour samples from over 1,000 consenting patients who are among the top three per cent in terms of cancer survival."
Read more
